Literature DB >> 33443490

An EUA for bamlanivimab - a monoclonal antibody for COVID-19.

.   

Abstract

Entities:  

Keywords:  COVID-19; adverse effects; bamlanivimab; coronavirus; dosage; efficacy; safety

Year:  2020        PMID： 33443490

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  1 in total

1.  Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19.

Authors:  Dennis M Bierle; Ravindra Ganesh; Caroline G Wilker; Sara N Hanson; Darcie E Moehnke; Tammy A Jackson; Priya Ramar; Jordan K Rosedahl; Lindsey M Philpot; Raymund R Razonable
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.